Showing results (41-50 of 151) with videos related to
Sort By:
Pageof 16
Journal of the International AIDS Society|March 21, 2019
ART adherence clubs in the Western Cape of South Africa: what does the sustainability framework tell us? A scoping literature reviewKornelia Flämig, Tom Decroo, Bart van den Borne, et al.International Health|September 14, 2013
Community-based antiretroviral therapy programs can overcome barriers to retention of patients and decongest health services in sub-Saharan Africa: a systematic reviewTom Decroo, Freya Rasschaert, Barbara Telfer, et al.The Lancet. Microbe|May 11, 2022
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in RwandaJean Claude Semuto Ngabonziza, Tom Decroo, Patrick Migambi, et al.Scientific Reports|February 21, 2018
Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutationsPauline Lempens, Conor J Meehan, Koen Vandelannoote, et al.Tropical Medicine & International Health : TM & IH|June 7, 2007
Endogenous reactivation and true treatment failure as causes of recurrent tuberculosis in a high incidence setting with a low HIV infectionIsdore Chola Shamputa, Armand Van Deun, Md Abdul Hamid Salim, et al.American Journal of Respiratory and Critical Care Medicine|May 6, 2010
Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosisArmand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim, et al.BMJ Open|July 25, 2024
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trialJihad Snobre, Joel Gasana, Jean Claude Semuto Ngabonziza, et al.International Health|October 12, 2023
Systematic review on cumulative HIV viraemia among people living with HIV receiving antiretroviral treatment and its association with mortality and morbidityAnita Mesic, Tom Decroo, Eric Florence, et al.Plos One|December 10, 2015
Social Consequences of Ebola Containment Measures in LiberiaUmberto Pellecchia, Rosa Crestani, Tom Decroo, et al.Lancet (London, England)|December 19, 2006
Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysisMohamed Abdel Aziz, Abigail Wright, Adalbert Laszlo, et al.Pageof 16